Veko Petmedin 1.25mg is a prescription-only veterinary cardiovascular medication formulated for the clinical management and treatment of mild, moderate, or severe congestive heart failure (CHF) in small and toy breed dogs. The active pharmaceutical ingredient, Pimobendan, functions as a highly effective "inodilator" that delivers a crucial dual mechanism of action: it operates as a calcium sensitizer to directly improve heart muscle contractility (positive inotropy) while simultaneously acting as a phosphodiesterase III (PDE3) inhibitor to dilate peripheral blood vessels.

This targeted action minimizes structural resistance in blood pathways, reduces the afterload and overall workload on weak heart chambers, and optimizes total cardiac output without increasing oxygen consumption. It is commonly prescribed to manage heart conditions resulting from atrioventricular valvular insufficiency (AVVI), Myxomatous Mitral Valve Disease (MMVD), or Dilated Cardiomyopathy (DCM), as well as to delay the onset of clinical heart failure in preclinical stages. Presented as highly palatable, protein-flavored chewable tablets (Yum-Tabs) that are easily split for precise micro-dosing, Petmedin 1.25mg significantly eases debilitating clinical symptoms like chronic coughing, breathlessness, and lethargy, substantially boosting everyday stamina and extending life expectancy in smaller canines.